A novel transgenic mouse model of Chinese Charcot-Marie-Tooth disease type 2L

Neural Regeneration Research

Volumn 9, Issue 4, 2014, Pages 413-419

  Zhang, Ruxu ^a   Zhang, Fufeng ^a   Li, Xiaobo ^a   Huang, Shunxiang ^a   Zi, Xiaohong ^a   Liu, Ting ^a   Liu, Sanmei ^a   Li, Xuning ^a   Xia, Kun ^a   Pan, Qian ^a   Tang, Beisha ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Animal models; Axonal injury; Charcot Marie Tooth disease type 2L; Gene mutation; Nerve regeneration; Neural regeneration; NSFC grant; Peripheral nerve injury; Pronuclear injection; Small heat shock protein B8; Transgenic model

Indexed keywords

COMPLEMENTARY DNA; HEAT SHOCK PROTEIN 22; RECOMBINASE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; ELECTROPHYSIOLOGY; FEMALE; GENE; GENE EXPRESSION; GENE MUTATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HISTOPATHOLOGY; HUMAN CYTOMEGALOVIRUS; IMMUNOPRECIPITATION; K141N GENE; K141N MUTATION; MALE; MOTOR COORDINATION; MOUSE; MUSCLE STRENGTH; NONHUMAN; PERIPHERAL NEUROPATHY; PHENOTYPE; POLYMERASE CHAIN REACTION; SCIATIC NERVE; TRANSGENIC MOUSE; VIRUS EXPRESSION; WESTERN BLOTTING;

EID: 84897106951     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.4103/1673-5374.128248     Document Type: Article

References (35)

1. thed. Philadelphia: Elsevier Saunders. 2005.
2. Patzkó A, Shy ME. Update on Charcot-Marie-Tooth disease. Curr Neurol Neurosci Rep. 2011;11(1):78-88.
3. Gentil BJ, Cooper L. Molecular basis of axonal dysfunction and traffic impairments in CMT. Brain Res Bull. 2012;88(5):444-453.
4. Siskind CE, Panchal S, Smith CO, et al. A review of genetic counseling for Charcot Marie Tooth disease (CMT). J Genet Couns. 2013;22(4):422-436.
5. Miller LJ, Saporta AS, Sottile SL, et al. Strategy for genetic testing in Charcot-Marie-disease. Acta Myol. 2011;30(2):109-116.
6. Tang BS, Luo W, Xia K, et al. A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2L) maps to chromosome 12q24. Hum Genet. 2004;114(6):527-533.
7. Tang BS, Zhao GH, Luo W, et al. Small heat-shock protein 22 mutated in autosomal dominant Charcot-Marie-Tooth disease type 2L. Hum Genet. 2005;116(3):222-224.
8. Zhang RX, Tang BS, Zi XH, et al. The construction of pEGFPN1-wtHSP22 and pEGFPN1-mtHSP22 vectors and their expressions in human neuroblastoma cells. Zhonghua Yi Xue Za Zhi. 2006;86(25):1780-1782.
9. Zhang RX, Tang BS, Zi XH, et al. Study on aggregate formation mechanism of HSPB8 gene mutation resulting in CMT2L. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006;23(6):601-604.
10. Ray PS, Martin JL, Swanson EA, et al. Transgene overexpression of alphaB crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion. FASEB J. 2001;15(2):393-402.
11. Ahmad S, Cesana F, Lamperti E, et al. Attenuation of angiotensin II-induced hypertension and cardiac hypertrophy in transgenic mice overexpressing a type 1 receptor mutant. Am J Hypertens. 2009;22(12):1320-1325.
12. Tang L, Yu CY, Feng R, et al. Establishment of PD-L1 transgenic mouse model and recovery of the motion after spinal cord injury. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011;27(4):357-359, 363.
13. Sereda M, Griffiths I, Pühlhofer A, et al. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron. 1996;16(5):1049-1060.
14. d'Ydewalle C, Krishnan J, Chiheb DM, et al. HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease. Nat Med. 2011;17(8):968-974.
15. Meyer Zu Hörste G, Nave KA. Animal models of inherited neuropathies. Curr Opin Neurol. 2006;19(5):464-473.
16. Patzkó A, Bai Y, Saporta MA, et al. Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice. Brain. 2012;135(Pt 12):3551-3566.
17. Irobi J, Van Impe K, Seeman P, et al. Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat Genet. 2004;36(6):597-601.
18. Timmerman V, De Jonghe P, Simokovic S, et al. Distal hereditary motor neuropathy type II (distal HMN II): mapping of a locus to chromosome 12q24. Hum Mol Genet. 1996;5(7):1065-1069.
19. Rossor AM, Kalmar B, Greensmith L, et al. The distal hereditary motor neuropathies. J Neurol Neurosurg Psychiatry. 2012;83(1):6-14.
20. Nobbio L, Mancardi G, Grandis M, et al. PMP22 transgenic dorsal root ganglia cultures show myelin abnormalities similar to those of human CMT1A. Ann Neurol. 2001;50(1):47-55.
21. Melli G, Höke A. Dorsal Root Ganglia Sensory Neuronal Cultures: a tool for drug discovery for peripheral neuropathies. Expert Opin Drug Discov. 2009;4(10):1035-1045.
22. Irobi J, Almeida-Souza L, Asselbergh B, et al. Mutant HSPB8 causes motor neuron-specific neurite degeneration. Hum Mol Genet. 2010;19(16):3254-3265.
23. Irobi J, Holmgren A, De Winter V, et al. Mutant HSPB8 causes protein aggregates and a reduced mitochondrial membrane potential in dermal fibroblasts from distal hereditary motor neuropathy patients. Neuromuscul Disord. 2012;22(8):699-711.
24. Li SJ, Tang BS, Zhao GH, et al. The effect of HSPB8 gene mutation on cell viability in Charcot-Marie-Tooth disease type 2L. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011;28(5):528-531.
25. Kwok AS, Phadwal K, Turner BJ, et al. HspB8 mutation causing hereditary distal motor neuropathy impairs lysosomal delivery of autophagosomes. J Neurochem. 2011;119(6):1155-1161.
26. Carra S, Seguin SJ, Landry J. HspB8 and Bag3: a new chaperone complex targeting misfolded proteins to macroautophagy. Autophagy. 2008;4(2):237-239.
27. Seidel K, Vinet J, Dunnen WF, et al. The HSPB8-BAG3 chaperone complex is upregulated in astrocytes in the human brain affected by protein aggregation diseases. Neuropathol Appl Neurobiol. 2012;38(1):39-53.
28. Nivon M, Abou-Samra M, Richet E, et al. NF-κB regulates protein quality control after heat stress through modulation of the BAG3-HspB8 complex. J Cell Sci. 2012;125(Pt 5):1141-1151.
29. Shemetov AA, Gusev NB. Biochemical characterization of small heat shock protein HspB8 (Hsp22)-Bag3 interaction. Arch Biochem Biophys. 2011;513(1):1-9.
30. Behl C. BAG3 and friends: co-chaperones in selective autophagy during aging and disease. Autophagy. 2011;7(7):795-798.
31. Norreel JC, Jamon M, Riviere G, et al. Behavioural profiling of a murine Charcot-Marie-Tooth disease type 1A model. Eur J Neurosci. 2001;13(8):1625-1634.
32. Kadotani H, Hirano T, Masugi M, et al. Motor discoordination results from combined gene disruption of the NMDA receptor NR2A and NR2C subunits, but not from single disruption of the NR2A or NR2C subunit. J Neurosci. 1996;16(24):7859-7867.
33. Zhao X, Ye J, Sun Q, et al. Antinociceptive effect of spirocyclopiperazinium salt compound LXM-15 via activating peripheral α7 nAChR and M4 mAChR in mice. Neuropharmacology. 2011;60(2-3):446-452.
34. Rodgers RJ. Effects of nicotine, mecamylamine, and hexamethonium on shock-induced fighting, pain reactivity, and locomotor behaviour in rats. Psychopharmacology (Berl). 1979;66(1):93-98.
35. Ma WQ, Wei HM, Dong FT, et al. Establishment of chronic neuropathic pain model by L4/5 spinal nerve ligature in rats. Kunming Yixueyuan Xuebao. 2010;31(6):57-60.